These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 27510266)

  • 81. Infiltrating neutrophils aggravate metabolic liver failure in fah-deficient mice.
    Qi Z; Wang X; Wei H; Sun R; Tian Z
    Liver Int; 2015 Mar; 35(3):774-85. PubMed ID: 24840069
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Purified hematopoietic stem cells can differentiate into hepatocytes in vivo.
    Lagasse E; Connors H; Al-Dhalimy M; Reitsma M; Dohse M; Osborne L; Wang X; Finegold M; Weissman IL; Grompe M
    Nat Med; 2000 Nov; 6(11):1229-34. PubMed ID: 11062533
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Identification and functional characterization of a novel homozygous intronic variant in the fumarylacetoacetate hydrolase gene in a Chinese patient with tyrosinemia type 1.
    Chen J; Sun J; Li X; Du M
    BMC Med Genomics; 2022 Dec; 15(1):251. PubMed ID: 36463171
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Adenine base editing in an adult mouse model of tyrosinaemia.
    Song CQ; Jiang T; Richter M; Rhym LH; Koblan LW; Zafra MP; Schatoff EM; Doman JL; Cao Y; Dow LE; Zhu LJ; Anderson DG; Liu DR; Yin H; Xue W
    Nat Biomed Eng; 2020 Jan; 4(1):125-130. PubMed ID: 31740768
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Hepatocytes corrected by gene therapy are selected in vivo in a murine model of hereditary tyrosinaemia type I.
    Overturf K; Al-Dhalimy M; Tanguay R; Brantly M; Ou CN; Finegold M; Grompe M
    Nat Genet; 1996 Mar; 12(3):266-73. PubMed ID: 8589717
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Therapeutic genome editing by combined viral and non-viral delivery of CRISPR system components in vivo.
    Yin H; Song CQ; Dorkin JR; Zhu LJ; Li Y; Wu Q; Park A; Yang J; Suresh S; Bizhanova A; Gupta A; Bolukbasi MF; Walsh S; Bogorad RL; Gao G; Weng Z; Dong Y; Koteliansky V; Wolfe SA; Langer R; Xue W; Anderson DG
    Nat Biotechnol; 2016 Mar; 34(3):328-33. PubMed ID: 26829318
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Transplanted bone marrow regenerates liver by cell fusion.
    Vassilopoulos G; Wang PR; Russell DW
    Nature; 2003 Apr; 422(6934):901-4. PubMed ID: 12665833
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Hypersuccinylacetonaemia and normal liver function in maleylacetoacetate isomerase deficiency.
    Yang H; Al-Hertani W; Cyr D; Laframboise R; Parizeault G; Wang SP; Rossignol F; Berthier MT; Giguère Y; Waters PJ; Mitchell GA;
    J Med Genet; 2017 Apr; 54(4):241-247. PubMed ID: 27876694
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Insulin-like growth factor 2 is a key mitogen driving liver repopulation in mice.
    Wang MJ; Chen F; Liu QG; Liu CC; Yao H; Yu B; Zhang HB; Yan HX; Ye Y; Chen T; Wangensteen KJ; Wang X; Hu YP; He ZY
    Cell Death Dis; 2018 Jan; 9(2):26. PubMed ID: 29348399
    [TBL] [Abstract][Full Text] [Related]  

  • 90.
    Nicolas CT; Kaiser RA; Hickey RD; Allen KL; Du Z; VanLith CJ; Guthman RM; Amiot B; Suksanpaisan L; Han B; Francipane MG; Cheikhi A; Jiang H; Bansal A; Pandey MK; Garg I; Lowe V; Bhagwate A; O'Brien D; Kocher JA; DeGrado TR; Nyberg SL; Lagasse E; Lillegard JB
    Mol Ther Methods Clin Dev; 2020 Sep; 18():738-750. PubMed ID: 32913881
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Molecular Pathogenesis of Liver Injury in Hereditary Tyrosinemia 1.
    Tanguay RM; Angileri F; Vogel A
    Adv Exp Med Biol; 2017; 959():49-64. PubMed ID: 28755183
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Tyrosinemia: a review.
    Russo PA; Mitchell GA; Tanguay RM
    Pediatr Dev Pathol; 2001; 4(3):212-21. PubMed ID: 11370259
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Generation of immunodeficient pig with hereditary tyrosinemia type 1 and their preliminary application for humanized liver.
    Ren J; Yu D; Wang J; Xu K; Xu Y; Sun R; An P; Li C; Feng G; Zhang Y; Dai X; Zhao H; Wang Z; Han Z; Zhu H; Ding Y; You X; Liu X; Wu M; Luo L; Li Z; Yang YG; Hu Z; Wei HJ; Ge L; Hai T; Li W
    Cell Biosci; 2022 Mar; 12(1):26. PubMed ID: 35255981
    [TBL] [Abstract][Full Text] [Related]  

  • 94. TRAP-seq identifies cystine/glutamate antiporter as a driver of recovery from liver injury.
    Wang AW; Wangensteen KJ; Wang YJ; Zahm AM; Moss NG; Erez N; Kaestner KH
    J Clin Invest; 2018 Jun; 128(6):2297-2309. PubMed ID: 29517978
    [TBL] [Abstract][Full Text] [Related]  

  • 95. The pathophysiology and treatment of hereditary tyrosinemia type 1.
    Grompe M
    Semin Liver Dis; 2001 Nov; 21(4):563-71. PubMed ID: 11745044
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Hepatocyte injury in tyrosinemia type 1 is induced by fumarylacetoacetate and is inhibited by caspase inhibitors.
    Kubo S; Sun M; Miyahara M; Umeyama K; Urakami K; Yamamoto T; Jakobs C; Matsuda I; Endo F
    Proc Natl Acad Sci U S A; 1998 Aug; 95(16):9552-7. PubMed ID: 9689118
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Noninvasive 3-dimensional imaging of liver regeneration in a mouse model of hereditary tyrosinemia type 1 using the sodium iodide symporter gene.
    Hickey RD; Mao SA; Amiot B; Suksanpaisan L; Miller A; Nace R; Glorioso J; O'Connor MK; Peng KW; Ikeda Y; Russell SJ; Nyberg SL
    Liver Transpl; 2015 Apr; 21(4):442-53. PubMed ID: 25482651
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Amelioration of an Inherited Metabolic Liver Disease through Creation of a De Novo Start Codon by Cytidine Base Editing.
    Yang L; Wang L; Huo Y; Chen X; Yin S; Hu Y; Zhang X; Zheng R; Geng H; Han H; Ma X; Liu M; Li H; Yu W; Liu M; Wang J; Li D
    Mol Ther; 2020 Jul; 28(7):1673-1683. PubMed ID: 32413280
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Clinical, biochemical, and genetic analysis of a Korean neonate with hereditary tyrosinemia type 1.
    Park HD; Lee DH; Choi TY; Lee YK; Kim JW; Ki CS; Lee YW
    Clin Chem Lab Med; 2009; 47(8):930-3. PubMed ID: 19569981
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Natural Killer Cells-Produced IFN-γ Improves Bone Marrow-Derived Hepatocytes Regeneration in Murine Liver Failure Model.
    Li L; Zeng Z; Qi Z; Wang X; Gao X; Wei H; Sun R; Tian Z
    Sci Rep; 2015 Sep; 5():13687. PubMed ID: 26345133
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.